What is the address of DR. NYS?

The registered office of DR. NYS is located at Dorpsstraat 8, 3590 Diepenbeek.

Is DR. NYS still active?

Yes. According to the CBE (30 October 2026) DR. NYS is active, legal situation “Normale toestand”, started on 24 December 2001.

Is DR. NYS registered on Peppol?

No, DR. NYS is currently not registered on the Peppol network.

What is the enterprise number of DR. NYS?

The enterprise number of DR. NYS is BE0476430841.

When was DR. NYS founded?

DR. NYS was founded on 24 December 2001.

Who are the directors of DR. NYS?

According to the 2025 annual accounts, the directors of DR. NYS are: Viviane Nys.

Is DR. NYS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. NYS make in 2025?

DR. NYS posted a profit after taxes of € 24,325 in financial year 2025.

What is the revenue of DR. NYS?

As a small company, DR. NYS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 47,952.

DR. NYS (Private Limited) - Diepenbeek - BE0476430841

Dossier DR. NYS, printed on 30 October 2026 from databakkes.be/en/0476430841/dr-nys. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. NYS from Diepenbeek, company number BE0476430841, closed financial year 2025 with a result of € 24,325 after tax. For that financial year DR. NYS recorded a gross margin of € 47,952 and equity of € 406,456. Compared with financial year 2024, the result moved from € 41,496 to € 24,325. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 406,456

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 24,325

▼ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 393,206

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 283,256.

People and assets in 2025

Vehicles and equipment

€ 19,249

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,906

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,732

▲ 159% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 69,912 Gross margin 2022: € 69,912 First fiscal year in the series	€ 66,413 Gross margin 2023: € 66,413 ▼ 5% vs 2022 (€ 69,912) Unfavourable step	€ 70,603 Gross margin 2024: € 70,603 ▲ 6% vs 2023 (€ 66,413) Favourable step	€ 47,952 Gross margin 2025: € 47,952 ▼ 32% vs 2024 (€ 70,603) Unfavourable step	▼ 32%
Profit after taxes	€ 50,951 Profit after taxes 2022: € 50,951 First fiscal year in the series	€ 35,899 Profit after taxes 2023: € 35,899 ▼ 30% vs 2022 (€ 50,951) Unfavourable step	€ 41,496 Profit after taxes 2024: € 41,496 ▲ 16% vs 2023 (€ 35,899) Favourable step	€ 24,325 Profit after taxes 2025: € 24,325 ▼ 41% vs 2024 (€ 41,496) Unfavourable step	▼ 41%
Equity	€ 304,736 Equity 2022: € 304,736 First fiscal year in the series	€ 340,635 Equity 2023: € 340,635 ▲ 12% vs 2022 (€ 304,736) Favourable step	€ 382,131 Equity 2024: € 382,131 ▲ 12% vs 2023 (€ 340,635) Favourable step	€ 406,456 Equity 2025: € 406,456 ▲ 6% vs 2024 (€ 382,131) Favourable step	▲ 6%
Total debts	€ 66,905 Total debts 2022: € 66,905 First fiscal year in the series	€ 10,236 Total debts 2023: € 10,236 ▼ 85% vs 2022 (€ 66,905) Favourable step	€ 25,015 Total debts 2024: € 25,015 ▲ 144% vs 2023 (€ 10,236) Unfavourable step	€ 29,363 Total debts 2025: € 29,363 ▲ 17% vs 2024 (€ 25,015) Unfavourable step	▲ 17%
Cash	€ 252,678 Cash 2022: € 252,678 First fiscal year in the series	€ 284,405 Cash 2023: € 284,405 ▲ 13% vs 2022 (€ 252,678) Favourable step	€ 359,492 Cash 2024: € 359,492 ▲ 26% vs 2023 (€ 284,405) Favourable step	€ 393,206 Cash 2025: € 393,206 ▲ 9% vs 2024 (€ 359,492) Favourable step	▲ 9%
Retained profit	€ 181,536 Retained profit 2022: € 181,536 First fiscal year in the series	€ 217,435 Retained profit 2023: € 217,435 ▲ 20% vs 2022 (€ 181,536) Favourable step	€ 258,931 Retained profit 2024: € 258,931 ▲ 19% vs 2023 (€ 217,435) Favourable step	€ 283,256 Retained profit 2025: € 283,256 ▲ 9% vs 2024 (€ 258,931) Favourable step	▲ 9%
Balance sheet total	€ 371,641 Balance sheet total 2022: € 371,641 First fiscal year in the series	€ 350,871 Balance sheet total 2023: € 350,871 ▼ 6% vs 2022 (€ 371,641) Unchanged	€ 407,146 Balance sheet total 2024: € 407,146 ▲ 16% vs 2023 (€ 350,871) Unchanged	€ 435,819 Balance sheet total 2025: € 435,819 ▲ 7% vs 2024 (€ 407,146) Unchanged	▲ 7%

Key figures of DR. NYS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. NYS?

What happened at DR. NYS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 24,325 (▼ 41% vs 2024). Source: NBB ↗
2002 Viviane Nys became a director. NBB
Dec 24, 2001 New establishment in Diepenbeek. KBO
Dec 24, 2001 Start of the company according to the CBE. KBO

In short

From € 50,951 profit in 2022 to € 24,325 profit in 2025.

Paid € 67,164 in corporate taxes since 2022.

Best year ever: 2022, with € 50,951 profit.

Original PDFs at the National Bank ↗

Management

Viviane Nys

DR. NYS

DEMERHUIS

Behind DR. NYS is Viviane Nys. Viviane Nys is also behind DEMERHUIS.

Directors

According to the 2025 annual accounts

Viviane Nys

Manager

Also active at: DEMERHUIS

since 2002

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 8

3590 Diepenbeek

2.307.789.356

Stationsstraat 28

3590 Diepenbeek

Active since 24 December 2001

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.430.841
VAT number: BE 0476.430.841
Registered office: Dorpsstraat 8, 3590 Diepenbeek
Names & denominations: DR. NYS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2001
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗